Neuroscientific Biopharmaceuticals Ltd (NSB) — Financial Flexibility Index
Neuroscientific Biopharmaceuticals Ltd (NSB) has a Financial Flexibility Index of -3.22x as of June 2025. Free cash flow of AU$-480.55K (operating CF AU$-480.55K minus capex AU$0.00) represents -3% of total liabilities (AU$149.22K). Check Neuroscientific Biopharmaceuticals Ltd (NSB) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Neuroscientific Biopharmaceuticals Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Neuroscientific Biopharmaceuticals Ltd across 10 annual periods. See NSB working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Neuroscientific Biopharmaceuticals Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for Neuroscientific Biopharmaceuticals Ltd. For the full company profile including market capitalisation, see Neuroscientific Biopharmaceuticals Ltd (NSB) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.31x | AU$-941.33K | AU$-941.33K | AU$149.22K | ▼ -1273.4% |
| 2024 | 0.54x | AU$46.06K | AU$44.25K | AU$85.68K | ▲ +113.9% |
| 2023 | -3.86x | AU$-2.30 Million | AU$-2.30 Million | AU$597.36K | ▼ -23.3% |
| 2022 | -3.13x | AU$-6.94 Million | AU$-6.94 Million | AU$2.22 Million | ▲ +72.8% |
| 2021 | -11.51x | AU$-2.57 Million | AU$-2.60 Million | AU$223.41K | ▲ +55.3% |
| 2020 | -25.74x | AU$-2.28 Million | AU$-2.28 Million | AU$88.53K | ▼ -15.8% |
| 2019 | -22.22x | AU$-1.39 Million | AU$-1.41 Million | AU$62.48K | ▼ -254.5% |
| 2018 | -6.27x | AU$-478.83K | AU$-497.91K | AU$76.39K | ▼ -57.8% |
| 2017 | -3.97x | AU$-171.42K | AU$-186.42K | AU$43.15K | ▼ -523.9% |
| 2016 | -0.64x | AU$-77.76K | AU$-87.76K | AU$122.12K | — |